# A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms

> **NCT00541346** · PHASE3 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 16 (actual)

## Conditions studied

- Autism
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate Transdermal System

## Key facts

- **NCT ID:** NCT00541346
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-05
- **Final completion:** 2010-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541346, "A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00541346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*